A carregar...
Changes in the Prescription of Glucose‐Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study
BACKGROUND: Evidence accumulated that some glucose‐lowering medications protect against cardiovascular events (CVEs) in patients with type 2 diabetes mellitus (T2DM) and established cardiovascular disease. The present study evaluated if and how glucose‐lowering medication prescription pattern change...
Na minha lista:
| Publicado no: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6662129/ https://ncbi.nlm.nih.gov/pubmed/31269877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.012244 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|